Tomotaka Mabuchi

2.1k citations
72 papers · 1.4k indexed · h-index 20
Topics
Psoriasis: Treatment and Pathogenesis (30 papers)Dermatology and Skin Diseases (18 papers)Asthma and respiratory diseases (8 papers)

In The Last Decade

Tomotaka Mabuchi

65 papers receiving 1.4k citations

Peers

Tomotaka Mabuchi
Comparison fields: 5 of 101
  • Immunology 1.0k
  • Dermatology 638
  • Physiology 219
  • Molecular Biology 200
  • Pathology and Forensic Medicine 185
Replace Satveer K. Mahil with:
Satveer K. Mahil United Kingdom
Gamze Pişkin Netherlands
Antonella Di Cesare Italy
Melodie Young United States
Nicholas Gulati United States
Jason E. Hawkes United States
Hekla Sigmundsdóttir Iceland
Luca Potestio Italy
Kristina Lee United States
Efterpi Zafiriou Greece
Tomotaka Mabuchi relative to Satveer K. Mahil United Kingdom Satveer K. Mahil's profile →
Citations per field
00.5×1.5×1.8×
Satveer K. Mahil · 1×
Citations per year

Countries citing papers authored by Tomotaka Mabuchi

Since Specialization
Citations

This map shows the geographic impact of Tomotaka Mabuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomotaka Mabuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomotaka Mabuchi more than expected).

Fields of papers citing papers by Tomotaka Mabuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomotaka Mabuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomotaka Mabuchi. The network helps show where Tomotaka Mabuchi may publish in the future.

Co-authorship network of co-authors of Tomotaka Mabuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Tomotaka Mabuchi. A scholar is included among the top collaborators of Tomotaka Mabuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomotaka Mabuchi. Tomotaka Mabuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2
Case of Exacerbation of Psoriasis Following COVID-19 Vaccination During Treatment with Brodalumab, Which Resulted in Secondary Failure.
1
3 2
4 6
5 7
6 25
7 1
8 11
9 31
10
Emerging therapies in psoriasis
0
11
Random skin biopsy of intravascular large B-cell lymphoma: a case report.
9
12 0
13 110
14 46
15 6
16 79
17 4
18 54
19 5
20 2

About Tomotaka Mabuchi

Tomotaka Mabuchi is a scholar working on Dermatology, Immunology and Microbiology, having authored 72 papers that have together received 1.4k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (30 papers), Dermatology and Skin Diseases (18 papers) and Asthma and respiratory diseases (8 papers). The work is most often cited by research in Dermatology (638 citations), Immunology (1.0k citations) and Microbiology (10 citations). Tomotaka Mabuchi has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Tomonori Takekoshi, Sam T. Hwang, Akira Ozawa, Hidetoshi Inoko, Samuel Hwang, Akira Ozawa, Akira Oka, Shigaku Ikeda, Keiji Iwatsuki and N. Hirayama. Their work appears in journals such as The Journal of Immunology, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026